Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04638920Completed

Molecular Breath Print of COPD Patients With Exacerbations Despite Triple Inhalational Therapy

Role: collaborator

NCT05456009Recruiting

Exhaled Breath Analysis in Human Subjects

Role: collaborator

NCT05458934Recruiting

Analysis of Exhaled Breath From Patients With Lung-/Airway Diseases (BigExBrESs)

Role: collaborator

All 3 trials loaded